ArticleCancer medicine2026

Prognostic Value of Next-Generation Flow Cytometry Versus Dual-Tracer PET/CT for Minimal Residual Disease Assessment in Multiple Myeloma.

Runfeng Zhang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.